Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Dec 18 2024

Full Issue

Sanofi Is The Latest To Sue HHS Over 340B Drug Discount Model Changes

The claim was filed Monday, alleging the federal government lacks the authority to stop the company from implementing the proposed rebate model. Other news is on staffing shortages; health claim denial rates; and more.

Sanofi has joined several other pharmaceutical manufacturers suing the federal government over its moves to block the companies' proposed changes to how they issue 340B drug discounts. Sanofi sued the Health and Human Services Department and the Health Resources and Services Administration Monday, alleging the agencies do not have the authority to stop the company from implementing a rebate model for the 340B drug pricing program. (Kacik, 12/17)

The man in the hospital bed is named Morgan Therin. He’s obese, sixtyish, and Black, with symptoms of Alzheimer’s disease. The student assigned to care for him has hardly any real-world experience. Yet the student expected to record the man’s vital signs, give him an injection, and explain what’s happening to a patient who can barely understand him. It’s the kind of challenge faced by countless nursing students. But it’s a little easier when the patient doesn’t exist. (Bray, 12/17)

Illinois state health officials approved Prime Healthcare’s deal to buy 11 hospitals and care sites from Catholic health system Ascension Illinois, marking one of the largest local hospital deals of the year. The $375 million deal, first announced in July, got the unanimous approval of the Illinois Health Facilities & Services Review Board at a meeting in Bolingbrook today. Board members probed about Prime’s relationship with its nurses, its decision to retain the facilities’ Catholic values, investment initiatives and litigation scandals, but ultimately signed off on the transaction. (Davis, 12/17)

Health Advocates Network continues to expand with the acquisition of Staff America Medical Staffing, its fourth in the fourth quarter. The deal was announced and closed today. Staff America is based in Ocala, Florida, and specializes in placing registered nurses, licenses practical nurses/licensed vocational nurses and therapists on both local and travel assignments in Florida and the Midwest. It was founded in 2001. (Johnson, 12/17)

Also —

Health equity has improved little in the U.S. despite many efforts, according to a panel discussion on Monday. "Are we doing better? Are we doing worse? If we look at the numbers, most of it is that we're the same. On ending unequal treatment, we found that the progress is minimal. We're really not there," said Margarita Alegria, PhD, chief of the Disparities Research Unit at Mass General Hospital in Boston, at an event on health disparities sponsored by Health Affairs and the consulting firm Deloitte. (Frieden, 12/17)

Just over a third of U.S. psychologists say they don't accept any type of health insurance, according to the American Psychological Association's latest annual provider survey. The lack of mental health professionals in insurer networks can make it difficult for Americans to access counseling or other behavioral care. (Goldman, 12/18)

Three of Maryland’s top health insurers have higher than average claim denial rates, according to research that’s gained traction in the wake of the fatal shooting of UnitedHealthcare CEO Brian Thompson and the arrest of suspect and Baltimore area native Luigi Nicholas Mangione. UnitedHealthcare, Maryland’s third-largest health insurer by market share, ranked first in failure to pay, denying about one-third, or 32%, of claims in 2022, said an analysis by consumer research site ValuePenguin, a subsidiary of LendingTree. (Mirabella, 12/17)

Â鶹ŮÓÅ Health News: Listen To The Latest 'Â鶹ŮÓÅ Health News Minute'

This week on the Â鶹ŮÓÅ Health News Minute: Community groups are working to restore the cemeteries of closed psychiatric hospitals, and some hospitals are looking for new ways to help patients keep up with the utility bills. (12/17)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ